From Surf Wiki (app.surf) — the open knowledge base
Amlodipine/olmesartan
Combination antihypertensive drug
Combination antihypertensive drug
| Field | Value |
|---|---|
| type | combo |
| component1 | Amlodipine |
| class1 | Calcium channel blocker |
| component2 | Olmesartan |
| class2 | Angiotensin II antagonist |
| tradename | Azor, Sevikar |
| Drugs.com | |
| DailyMedID | Amlodipine and olmesartan |
| pregnancy_AU | D |
| pregnancy_AU_comment | |
| routes_of_administration | By mouth |
| ATC_prefix | C09 |
| ATC_suffix | DB02 |
| legal_AU | S4 |
| legal_AU_comment | |
| legal_BR | |
| legal_CA | |
| legal_DE | |
| legal_NZ | |
| legal_UK | POM |
| legal_UK_comment | |
| legal_US | Rx-only |
| legal_US_comment | |
| legal_UN | |
| legal_status | |
| CAS_number | 28981-97-7 |
| KEGG | D10285 |
| synonyms | Olmesartan/amlodipine |
| Drugs.com =
Amlodipine/olmesartan, sold under the brand name Azor, among others is a fixed-dose combination medication used to treat high blood pressure. It contains amlodipine, as the besilate, a dihydropyridine calcium channel blocker, and olmesartan medoxomil, an angiotensin II receptor blocker.
Amlodipine/olmesartan was approved for medical use in the United States in September 2007. It is available as a generic medication.
Medical uses
The combination is indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure.
History
The combination has been studied in clinical trials; one test showed it reduced blood pressure during a 24-hour period and was well tolerated.
References
References
- "TGA eBS - Product and Consumer Medicine Information Licence".
- "OLAMLO, OLMAKAR, OLMESARTAN/AMLODIPINE ASTRON, OLMESARTAN/AMLODIPINE INTAS (Accord Healthcare Pty Ltd)".
- (27 May 2022). "SEVIKAR 20/5 olmesartan medoxomil / amlodipine (as besilate) 20/5 mg tablet blister pack (157565)".
- (11 July 2022). "Sevikar 20 mg/5 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC)".
- (7 September 2022). "Azor- amlodipine besylate and olmesartan medoxomil tablet, film coated".
- (7 June 2022). "Azor- amlodipine besylate and olmesartan medoxomil tablet, film coated".
- (May 2025). "Drug Approval Package: Azor (amlodipine and olmesartan medoxomil) NDA #022100".
- (June 2009). "American society of hypertension and american urological association". Pharmacy & Therapeutics.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Amlodipine/olmesartan — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report